Here’s what you should know.
1. Mr. Saunders presented at the 35th annual J.P. Morgan Healthcare Conference where he said the company has a goal “to have a very strong balance between R&D deals and accretive deals.”
2. Allergan announced its intent to acquire LifeCell Corp. for $2.9 billion on Dec. 20, 2016.
It also recently bought out Vitae Pharmaceuticals for $639 million.
3. Mr. Saunders said the company’s six therapies currently in phase 3 development could be worth up to $13 billion in peak sales.
4. Between 2016 and 2017, Allergan plans to launch 11 new products. Predictions say the launches could generate approximately $5 billion in sales for the company.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Bradley Zins of the Billings Clinic
ASGE certifies Mercy Hospital: 3 things to know
Dr. Brian Davis hosts video on The Fundamentals of Endoscopic Surgery exam
